Pfizer articles
-
DiNuzzo Private Wealth Inc. Makes New Investment in Pfizer Inc. (NYSE:PFE)
DiNuzzo Private Wealth Inc. bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,291 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other institutional […]
-
Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products
Shares of the U.S. drugmaker have lost 11% of their value this year on worries over its growth after the pandemic as billions of dollars in COVID vaccine and treatment sales evaporated. Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment Paxlovid. Revenue from Comirnaty, for which it partners with Germany's BioNTech, continues to perform consistently with its expectations, Pfizer said.
-
Look ahead: Fed rate decision; Japan consumer confidence; eBay; Pfizer; Qualcomm
US interest rates are expected to stay on hold. Japan releases its latest consumer confidence print. After Amazon's results, investors brace...